Table of Contents

October 01 1999; volume 48 issue 10

You have accessRestricted Access
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
E Duh and L P Aiello

Diabetes 1999 Oct; 48 (10): 1899-1906. https://doi.org/10.2337/diabetes.48.10.1899

Add to Selected Citations
You have accessRestricted Access
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?
W Bennet, B Sundberg, C G Groth, M D Brendel, D Brandhorst, H Brandhorst, R G Bretzel, G Elgue, R Larsson, B Nilsson and O Korsgren

Diabetes 1999 Oct; 48 (10): 1907-1914. https://doi.org/10.2337/diabetes.48.10.1907

Add to Selected Citations
You have accessRestricted Access
No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.
S G Hasselbalch, G M Knudsen, C Videbaek, L H Pinborg, J F Schmidt, S Holm and O B Paulson

Diabetes 1999 Oct; 48 (10): 1915-1921. https://doi.org/10.2337/diabetes.48.10.1915

Add to Selected Citations
You have accessRestricted Access
Tyrosine phosphorylation of specific protein kinase C isoenzymes participates in insulin stimulation of glucose transport in primary cultures of rat skeletal muscle.
L Braiman, L Sheffi-Friedman, A Bak, T Tennenbaum and S R Sampson

Diabetes 1999 Oct; 48 (10): 1922-1929. https://doi.org/10.2337/diabetes.48.10.1922

Add to Selected Citations
You have accessRestricted Access
Calorie restriction increases insulin-stimulated glucose transport in skeletal muscle from IRS-1 knockout mice.
A C Gazdag, C L Dumke, C R Kahn and G D Cartee

Diabetes 1999 Oct; 48 (10): 1930-1936. https://doi.org/10.2337/diabetes.48.10.1930

Add to Selected Citations
You have accessRestricted Access
Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes.
E Harfouch-Hammoud, T Walk, H Otto, G Jung, J F Bach, P M van Endert and S Caillat-Zucman

Diabetes 1999 Oct; 48 (10): 1937-1947. https://doi.org/10.2337/diabetes.48.10.1937

Add to Selected Citations
You have accessRestricted Access
T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes.
M E Pauza, H Neal, A Hagenbaugh, H Cheroutre and D Lo

Diabetes 1999 Oct; 48 (10): 1948-1953. https://doi.org/10.2337/diabetes.48.10.1948

Add to Selected Citations
You have accessRestricted Access
Mechanisms of glucose hypersensitivity in beta-cells from normoglycemic, partially pancreatectomized mice.
F Martín, E Andreu, J M Rovira, J A Pertusa, M Raurell, C Ripoll, J V Sanchez-Andrés, E Montanya and B Soria

Diabetes 1999 Oct; 48 (10): 1954-1961. https://doi.org/10.2337/diabetes.48.10.1954

Add to Selected Citations
You have accessRestricted Access
Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid.
S Andrikopoulos, C B Verchere, J C Teague, W M Howell, W Y Fujimoto, T N Wight and S E Kahn

Diabetes 1999 Oct; 48 (10): 1962-1970. https://doi.org/10.2337/diabetes.48.10.1962

Add to Selected Citations
You have accessRestricted Access
Mechanisms of coordination of Ca2+ signals in pancreatic islet cells.
F Bertuzzi, A M Davalli, R Nano, C Socci, F Codazzi, R Fesce, V Di Carlo, G Pozza and F Grohovaz

Diabetes 1999 Oct; 48 (10): 1971-1978. https://doi.org/10.2337/diabetes.48.10.1971

Add to Selected Citations
You have accessRestricted Access
Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype.
D Flamez, P Gilon, K Moens, A Van Breusegem, D Delmeire, L A Scrocchi, J C Henquin, D J Drucker and F Schuit

Diabetes 1999 Oct; 48 (10): 1979-1986. https://doi.org/10.2337/diabetes.48.10.1979

Add to Selected Citations
You have accessRestricted Access
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.
L Scheja, L Makowski, K T Uysal, S M Wiesbrock, D R Shimshek, D S Meyers, M Morgan, R A Parker and G S Hotamisligil

Diabetes 1999 Oct; 48 (10): 1987-1994. https://doi.org/10.2337/diabetes.48.10.1987

Add to Selected Citations
You have accessRestricted Access
In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression.
J S Harmon, C E Gleason, Y Tanaka, E A Oseid, K K Hunter-Berger and R P Robertson

Diabetes 1999 Oct; 48 (10): 1995-2000. https://doi.org/10.2337/diabetes.48.10.1995

Add to Selected Citations
You have accessRestricted Access
Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
J Kawaki, K Nagashima, J Tanaka, T Miki, M Miyazaki, T Gonoi, N Mitsuhashi, N Nakajima, T Iwanaga, H Yano and S Seino

Diabetes 1999 Oct; 48 (10): 2001-2006. https://doi.org/10.2337/diabetes.48.10.2001

Add to Selected Citations
You have accessRestricted Access
Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1.
E Roche, J Buteau, I Aniento, J A Reig, B Soria and M Prentki

Diabetes 1999 Oct; 48 (10): 2007-2014. https://doi.org/10.2337/diabetes.48.10.2007

Add to Selected Citations
You have accessRestricted Access
Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas.
C Saillan-Barreau, M Dufresne, P Clerc, D Sanchez, H Corominola, C Moriscot, O Guy-Crotte, C Escrieut, N Vaysse, R Gomis, N Tarasova and D Fourmy

Diabetes 1999 Oct; 48 (10): 2015-2021. https://doi.org/10.2337/diabetes.48.10.2015

Add to Selected Citations
You have accessRestricted Access
Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia.
R M O'Doherty, D L Lehman, S Télémaque-Potts and C B Newgard

Diabetes 1999 Oct; 48 (10): 2022-2027. https://doi.org/10.2337/diabetes.48.10.2022

Add to Selected Citations
You have accessRestricted Access
Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
K Ebihara, Y Ogawa, G Katsuura, Y Numata, H Masuzaki, N Satoh, M Tamaki, T Yoshioka, M Hayase, N Matsuoka, M Aizawa-Abe, Y Yoshimasa and K Nakao

Diabetes 1999 Oct; 48 (10): 2028-2033. https://doi.org/10.2337/diabetes.48.10.2028

Add to Selected Citations
You have accessRestricted Access
Rapid increase in circulating leptin in ventromedial hypothalamus-lesioned rats: role of hyperinsulinemia and implication for upregulation mechanism.
A Suga, T Hirano, H Kageyama, M Kashiba, J Oka, T Osaka, Y Namba, M Tsuji, M Miura, M Adachi and S Inoue

Diabetes 1999 Oct; 48 (10): 2034-2038. https://doi.org/10.2337/diabetes.48.10.2034

Add to Selected Citations
You have accessRestricted Access
Insulin resistance during puberty: results from clamp studies in 357 children.
A Moran, D R Jacobs, J Steinberger, C P Hong, R Prineas, R Luepker and A R Sinaiko

Diabetes 1999 Oct; 48 (10): 2039-2044. https://doi.org/10.2337/diabetes.48.10.2039

Add to Selected Citations
You have accessRestricted Access
Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
Y Kishi, J D Schmelzer, J K Yao, P J Zollman, K K Nickander, H J Tritschler and P A Low

Diabetes 1999 Oct; 48 (10): 2045-2051. https://doi.org/10.2337/diabetes.48.10.2045

Add to Selected Citations
You have accessRestricted Access
Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo.
E Bonnardel-Phu, J L Wautier, A M Schmidt, C Avila and E Vicaut

Diabetes 1999 Oct; 48 (10): 2052-2058. https://doi.org/10.2337/diabetes.48.10.2052

Add to Selected Citations
You have accessRestricted Access
Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes.
J Ren, L J Dominguez, J R Sowers and A J Davidoff

Diabetes 1999 Oct; 48 (10): 2059-2065. https://doi.org/10.2337/diabetes.48.10.2059

Add to Selected Citations
You have accessRestricted Access
Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.
R Singh, N Alavi, A K Singh and D J Leehey

Diabetes 1999 Oct; 48 (10): 2066-2073. https://doi.org/10.2337/diabetes.48.10.2066

Add to Selected Citations
You have accessRestricted Access
Low phagocytic activity of resident peritoneal macrophages in diabetic mice: relevance to the formation of advanced glycation end products.
B F Liu, S Miyata, H Kojima, A Uriuhara, H Kusunoki, K Suzuki and M Kasuga

Diabetes 1999 Oct; 48 (10): 2074-2082. https://doi.org/10.2337/diabetes.48.10.2074

Add to Selected Citations
You have accessRestricted Access
Regulation of the laminin C1 promoter in cultured mesangial cells.
S L Phillips, F R DeRubertis and P A Craven

Diabetes 1999 Oct; 48 (10): 2083-2089. https://doi.org/10.2337/diabetes.48.10.2083

Add to Selected Citations
You have accessRestricted Access
A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.
J Nakamura, K Kato, Y Hamada, M Nakayama, S Chaya, E Nakashima, K Naruse, Y Kasuya, R Mizubayashi, K Miwa, Y Yasuda, H Kamiya, K Ienaga, F Sakakibara, N Koh and N Hotta

Diabetes 1999 Oct; 48 (10): 2090-2095. https://doi.org/10.2337/diabetes.48.10.2090

Add to Selected Citations
You have accessRestricted Access
Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance.
J Walston, M Seibert, C J Yen, L J Cheskin and R E Andersen

Diabetes 1999 Oct; 48 (10): 2096-2098. https://doi.org/10.2337/diabetes.48.10.2096

Add to Selected Citations
You have accessRestricted Access
Hepatocyte nuclear factor-4gamma: cDNA sequence, gene organization, and mutation screening in early-onset autosomal-dominant type 2 diabetes.
N Plengvidhya, A Antonellis, L T Wogan, A Poleev, M Borgschulze, J H Warram, G U Ryffel, A S Krolewski and A Doria

Diabetes 1999 Oct; 48 (10): 2099-2102. https://doi.org/10.2337/diabetes.48.10.2099

Add to Selected Citations